Post by Agomab

Today, Agomab CEO Tim Knotnerus participated in a lively panel discussion at the J.P. Morgan European Healthcare Symposium in London. During the session, titled ‘From Private to Public: Navigating Fundraising in an Awakening Market', Tim shared perspectives on the evolving healthcare capital markets ecosystem and the broader trends shaping the sector, including the role of AI. #Agomab #AGMB #JPM #EuropeanHealthcare #LifeSciences #Innovation #Financing